Susan Sheridan, MD
Obstetrics & Gynecology · Casper, WYNPI 1891751533
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AbbVie at 30.7% of the total. Reporting peaked in 2021 at $265 and has fallen 57.2% since, to $113 in 2025.
Across 40 payments — averaging $16.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$198
- Astellas Pharma US Inc$113
- Merck$95
- Myovant Sciences Inc.$65
- Organon$43
- Hologic Sales And Service, LLC$27
- plus $106 from 7 others
What the payments were for
- Food & beverage$63197%
- Education$163%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 11 | $198 |
| Astellas Pharma US Inc | 4 | $113 |
| Merck | 7 | $95 |
| Myovant Sciences Inc. | 4 | $65 |
| Organon | 6 | $43 |
| Hologic Sales And Service, LLC | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Pfizer | 1 | $17 |
| Roche Diagnostics Corporation | 1 | $16 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $15 |
| Bayer | 1 | $15 |
| Exact Sciences | 1 | $13 |
| Exeltis, USA Inc. | 1 | $13 |
How this compares
$647 in reported general payments places this provider in the 65th percentile of 58 obstetrics & gynecology providers in Wyoming.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 11 | $562 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $312 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Casper
- Melissa HiebCasper$7K
- Carrie MerrillCasper$780
- Brittany MyersCasper$650
- Samuel VigneriCasper$109
- Laura SmothersCasper$61
- Patricia BellCasper$19
- Samantha MichelenaCheyenne$15K
- Lindsay CapronSheridan$9K
- Roger BrecheenJackson$8K
- Shannon RobertsJackson$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.